In a hindlimb ischemia (HLI) mouse model, miR‐138‐5p was shown to negatively regulate LCN2 in skeletal muscle, identifying a potential miR‐138/LCN2 axis in PAD pathophysiology [94]. This evidence concerns the gene LCN2 and peripheral arterial disease.